Translational Trends in Nanomedicine

Beilstein nanotechnology Symposium 2018

17 – 19 September, 2018
Hotel Jagdschloss Niederwald, Ruedesheim, Germany


Scientific Program:

Joerg Lahann / University of Michigan

Luis Liz-Marzán / CIC biomaGUNE, San Sebastian

Francesco Stellacci / EPFL, Lausanne

Molly Stevens / Imperial College London


The goal of this symposium is to identify and discuss translational trends and associated barriers in selected fields of nanomedicine that have particular promise for disruptive biotechnologies in the next decade. The contributors will be an interdisciplinary group of scientists ranging from engineers and basic scientist in nanotechnology to clinicians.


The symposium will take place in the Hotel Jagdschloss Niederwald on top of the Rheingau heights of Ruedesheim in Germany. The setting and the limited number of participants (max. 50 – 60 persons) provide a very convivial atmosphere for the ready exchange of thoughts and ideas.

Confirmed Speakers


Neus Feliu
University of Hamburg, Germany

Sharon Glotzer
University of Michigan, USA

Andreas Herrmann
DWI - Leibniz Institute for Interactive Materials, Germany

Nicholas A. Kotov
University of Michigan, USA

Joerg Lahann
University of Michigan, USA

Daniel Lauster
Free University of Berlin, Germany


Luis Liz-Marzán
CIC biomaGUNE, Spain

Alvaro Mata
Queen Mary University of London, UK

Nicholas Melosh
Stanford University, USA

Vladimir Muzykantov
University of Pennsylvania, USA

Wolfgang Parak
University of Hamburg, Germany

Maurizio Prato
University of Trieste, Italy


Ronit Sarid
Bar-Ilan University, Israel

Francesco Stellacci
EPFL, Switzerland

Molly Stevens
Imperial College London, UK

Millicent O. Sullivan
University of Delaware, USA

Joy Wolfram
Mayo Clinic, USA

Tian Xia
University of California, USA

Further Information